1
Participants
Start Date
July 31, 2013
Primary Completion Date
February 28, 2014
Study Completion Date
February 28, 2014
Iloperidone
"Subjects will receive oral iloperidone for 8 weeks. The first 2 weeks of treatment is called titration period and during this time the dose of iloperidone will be increased periodically from 1mg to a maximum of 8mg depending on response and tolerability.~During the remaining 6 weeks of treatment, called stable dose period, the subjects will receive a stable dose of iloperidone(defined during titration period)"
Placebo
During 8 weeks subjects will receive oral placebo
University of Colorado Depression Center; Clinical and Translational Research Center (CTRC), Aurora
Collaborators (1)
Novartis Pharmaceuticals
INDUSTRY
University of Colorado, Denver
OTHER